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Abstract.  Caveolae are 50-100-nm membrane 
microdomains that represent a subcompartment of the 
plasma membrane. Previous morphological studies 
have implicated caveolae in (a) the transcytosis of 
macromolecules (including LDL and modified LDLs) 
across capillary endothelial cells, (b) the uptake of 
small molecules via a process termed potocytosis in- 
volving GPI-linked receptor molecules and an un- 
known anion transport protein, (c) interactions with 
the actin-based cytoskeleton, and (d) the compartmen- 
talization of certain signaling molecules, including 
G-protein coupled receptors. Caveolin, a 22-kD inte- 
gral membrane protein, is an important structural 
component of caveolae that was first identified as a 
major v-Src substrate in Rous sarcoma virus trans- 
formed cells. This finding initially suggested a rela- 
tionship between caveolin, transmembrane signaling, 
and cellular transformation. 
We have recently developed a procedure for isolating 
caveolin-rich membrane domains from cultured cells. 
To facilitate biochemical manipulations, we have ap- 
plied this procedure to lung tissue-an endothelial and 
caveolin-rich source-allowing large scale preparation 
of these complexes. These membrane domains retain 
*85 % of caveolin and ,',,55 % of a GPI-linked marker 
protein, while they exclude I>98% of integral plasma 
membrane protein markers and t>99.6% of other 
organelle-specific membrane markers tested. Charac- 
terization of these complexes by micro-sequencing and 
immuno-blotting reveals known receptors for modified 
forms of LDL (scavenger receptors: CD 36 and 
RAGE), multiple GPI-linked proteins, an anion trans- 
porter (plasma membrane porin), cytoskeletal ele- 
ments, and cytoplasmic signaling molecules-including 
Src-like kinases, hetero-trimeric G-proteins, and three 
members of the Rap family of small GTPases (Rap 
I-the Ras tumor suppressor protein, Rap 2, and 
TC21).  At least a fraction of the actin in these com- 
plexes appeared monomeric (G-actin), suggesting that 
these domains could represent membrane bound sites 
for microfilament nucleation/assembly during signal- 
ing.  Given that the majority of these proteins are 
known molecules, our current studies provide a sys- 
tematic basis for evaluating these interactions in vivo. 
C 
AVEOLAE (alSO known as plasmalemmal vesicles) are 
,,o50-100-nm  membrane domains that represent a 
sub-compartment of the plasma membrane. How- 
ever, their specific morphology  may vary widely, even within 
a given cell type; they may be flat or invaginated, expressed 
singly or in bunches like clusters  of grapes (32,  76,  84). 
These  structures are most abundant in  simple  squamous 
epithelia (e.g., capillary endothelial cells and type I pneumo- 
cytes), fibroblasts, smooth muscle cells, and adipocytes (18, 
32, 35, 86). Although caveolae are thought to exist in most 
cell types, in vivo caveolar functioning has been most exten- 
sively studied in endothelial  cells. 
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In capillary endothelial  cells,  numerous morphological 
studies indicate that caveolae function in the transcytosis of 
certain blood-borne macromolecules (including  albumin, 
modified albumins,  LDL,  modified LDLs,  and advanced 
glycosylation end products [AGE's]  l) (31, 38, 85,  89,  100, 
105). As the endothelial caveolar transcytosis of lipoproteins 
is dramatically increased during hyperlipidemia,  it has been 
proposed that this transport mechanism contributes  to the 
sub-endothelial accumulation of LDL during atherosclerosis 
(85, 99). In light of these observations, it has been suggested 
1.  Abbreviations  used  in  this paper:  AGE,  advanced glycosylation end 
products; GPI, glycosyl-phosphatidylinositol; MBS, Mes-buffered saline; 
RAGE, receptor for advanced glycosylation end products; RSV, Rous sar- 
coma virus. 
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tified" scavenger receptors (defined as cell surface molecules 
that recognize modified LDL) (81), as the "classical" scaven- 
ger receptors are not expressed in endothelial cells (59).  Re- 
cently, two novel scavenger receptors expressed by endothe- 
lial ceils have been identified as CD 36 and receptor for 
advanced glycosylation  endproducts (RAGE) (30, 68). Inter- 
estingly, both of these receptors can also act as mitogenic 
signaling molecules (30, 49,  68). 
AGE formation (non-enzymatic glycosylation of serum 
proteins and lipids, including glycated LDL) and their cel- 
lular processing is thought to underlie the pathogenesis of 
diabetic vascular complications and normal aging (63).  In 
diabetic states, elevated levels of serum glucose lead to ac- 
celerated AGE formation and their sub-endothelial accumu- 
lation (63).  In accordance with these findings, AGEs un- 
dergo endothelial transcytosis via caveolae (31, 105),  and, 
in diabetic animal models, both the size and number of  endo- 
thelial caveolae increases at sites of diabetic microangiopathy 
(23). These results are consistent with the recent observation 
that RAGE-a lectin-like type I  transmembrane protein- 
appears to be localized within endothelial cell caveolae (80). 
Two additional functional roles  for caveolae have been 
proposed from the study of other cell types. These include 
(a) the translocation of small molecules from the extracellu- 
lar  environment  to  the  cell's  cytoplasm  via  glycosyl- 
phosphatidylinositol (GPI) linked protein receptors coupled 
to an unknown anion transporter protein, in a process termed 
potocytosis (7,  8);  and  (b)  as  a  sub-compartment of the 
plasma membrane involved in a  subset of transmembrane 
signaling events (6, 73,  74, 79, 95). 
Although the exact function of caveolae remains to be elu- 
cidated, several recent observations have led to a better un- 
derstanding of their molecular components. Morphological 
studies  indicate that caveolae concentrate certain classes 
of lipid-linked molecules (glyco-sphingolipids, cholesterol, 
and GPI-linked proteins), molecules that regulate calcium 
homeostasis (plasma membrane Ca  2+ pump;  IP3-sensitive 
Ca  2+ channel),  and G-protein related signaling molecules 
(multiple G-protein-coupled receptors, G-protein modifying 
bacterial toxins and adenylate cyclase activity) (7, 36, 37, 43, 
66, 71, 73, 74, 95,  102,  103). 
In the case of the muscarinic acetylcholine receptor (a 
G-protein coupled receptor), redistribution to plasmalemmal 
caveolae was agonist-induced and reversible, but did not oc- 
cur in response to receptor antagonists, consistent with the 
idea that these  structures  could participate  in  G-protein- 
coupled signaling (73). In addition, agonist-induced caveo- 
lar  localization  resulted  in  the  local  accumulation  of 
cytoskeletal elements-tentatively identified as  the actin- 
based cytoskeleton-in close contact with linear arrays of 
plasmalemmal caveolae (73). In further support of an associ- 
ation with actin, the cytoplasmic surface of caveolae is spe- 
cifically labeled in situ with an actin-binding protein, gold- 
conjugated myosin subfragment I (51, 52) and dystrophin- 
an actin-binding protein implicated in the pathogenesis of 
Duchenne's muscular dystrophy-has been immunolocalized 
to caveolae in smooth muscle cells (69).  In accordance with 
this localization, muscle cell caveolae undergo characteristic 
morphological changes in Duchenne's muscular dystrophy, 
but not in other forms of muscular dystrophy examined (14). 
Caveolin, a 22-kD transmembrane phospho-protein (40, 
42, 79),  is an important structural component of caveolae 
and contributes to their characteristic granular cytoplasmic 
appearance (76).  Immuno-gold localization of caveolin re- 
veals that it is confined to plasmalemmal caveolae and to a 
small extent within discrete tubulo-vesicular structures in the 
vicinity of  the trans-Golgi (29, 60). This may reflect the exis- 
tence of caveolae at the level of the trans-Golgi network. 
Originally identified as the major v-Src substrate in RSV- 
transformed cells, the phosphorylation of caveolin on tyro- 
sine residues is dependent on NH2-terminal myristoylation 
of v-Src (40,  42).  Similarly, myristoylation of v-Src is re- 
quired  to  confer cellular transformation.  Based on these 
studies, it has been implied that caveolin is the critical target 
for v-Src transformation. However, this observation has re- 
mained correlative. In light of the newly proposed view of 
caveolae as "signaling organelles  S caveolin phosphorylation 
by v-Src could constitutively activate their signaling capabil- 
ities, leading to unregulated cell growth (6, 79). 
As several caveolar membrane components (GPI-linked 
proteins, glyco-sphingolipids, and caveolin) are selectively 
resistant to solubilization by Triton X-100 at 4°C (20, 40, 42, 
45, 48, 61), we recently investigated the origin and composi- 
tion of low-density Triton-insoluble membrane domains iso- 
lated from tissue-cultured cells (79).  The unusual Triton- 
insolubility of  these domains has been attributed to their high 
glyco-sphingolipid content (20),  as glycosphingolipids are 
intrinsically Triton-insoluble (45, 94). Our results indicated 
that these domains derive from the cell surface, are dramati- 
cally enriched in caveolin and a GPI-linked marker protein, 
but that they exclude  ~>99% of total cell  surface-labeled 
plasma  membrane  proteins  and  a  battery  of organdie- 
specific marker  enzymes  for  non-caveolar plasma  mem- 
brane, Golgi, lysosomes, and ER. Low-angle rotary shadow- 
ing of these domains revealed that they are ,~50-100 nm in 
diameter  and  have  a  granular  appearance.  Similarly,  by 
transmission  EM,  they  are  50-100  nm  in  diameter  or 
greater-depending  on  the  cell  type-and  demonstrate a 
membrane bilayer.  In accordance with the morphological 
observations  that caveolae concentrate G-protein-coupled 
receptors and glycolipid binding bacterial toxins that mod- 
ify G-proteins,  these domains were  specifically enriched 
in hetero-trimeric G-protein alpha subunits (79).  In addi- 
tion,  in support of the observation that caveolin was first 
identified as a  major v-Src substrate,  these domains were 
also enriched in an endogenous Src-like kinase (c-Yes) and 
another v-Src substrate (annexin II) (79).  As many similari- 
ties exist between these membrane domains and caveolae, we 
have suggested that these structures represent isolated caveo- 
lae (see [79] for discussion of  this point). However, to distin- 
guish these domains from caveolae seen in electron micro- 
graphs of intact cells,  we have chosen the biochemically 
descriptive term, "caveolin-rich membrane domains," to re- 
fer to these complexes. 
To systematically identify other components of these com- 
plexes,  we have isolated caveolin-rich membrane domains 
from an endothelial-rich tissue source, i.e., lung, where cav- 
eolin demonstrates its highest known levels of expression. 
Our current characterization of these complexes reveals the 
identities of the major protein components of these mem- 
brane domains. It should be noted that although low-density 
Triton-insoluble membrane domains were initially isolated 
from cultured cells more than a decade ago (64), this is the 
first systematic characterization of their protein components. 
This first step should allow us and others to further evaluate 
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functioning in situ. 
Materials and Methods 
Materials 
Antibodies and their sources were as follows: caveolin, protein kinase C-t~ 
isoform, pan-ERK/MAP kinase, GRB-2, Vav, PI-3 kinase (p85), PTP-1D, 
annexin II- heavy chain, Ras-GAP, ISGE SHC, PLC~', Rap 2 (Transduc- 
tion Laboratories);  CD  36 (Accurate);  c-Src,  Fyn (Oncogene  Sciences, 
Manhasset, NY); c-Yes (gift of M. Sudol, The Rockefeller University, NY); 
Lyn,  Lck,  c-Fgr, Rapl, Rho A, Rho B, RB (Santa Cruz Biotechnology); 
JAK-2, Rap 1, Ras, casein kinase II (Upstate Biotechnology, Inc.); actin, 
non-muscle myosin II-heavy chain (Biomedical Technologies, Inc.); gelso- 
tin (Sigma Chem.  Co.,  St.  Louis,  MO);  G  protein-/J common (Dupont/ 
NEN, Wilmington, DE), Rab 3D (gift of Drs. G. Baldini and H.  Lodish, 
Whitehead Institute), G protein-~ subunits (gift of Dr.  A.  Spiegel, NIH, 
MD); Na+K+-ATPase, ~subunit (gift of Dr. M. Caplan, Yale University); 
p45, cell surface integral membrane protein (gift of Dr. J. E  Hare, Oregon 
Health Sciences University). 
Isolation of Caveolin-rich Membrane Domains 
Caveolin-rich membrane domains were prepared from mouse lung by a mi- 
nor modification of an established protocol used for cultured cells (20, 79). 
Mouse lungs (one pair; 400 mg wet weight) were minced with a scissor and 
homogenized with 2  mi of Mes-buffered saline (MBS; 25 mM Mes, pH 
6.5,  0.15  M  NaC1)  containing  1%  Triton  X-100  and  1  mM  PMSE 
Homogenization was carried out initially with 10 strokes of a loose-fitting 
Dounce homogenizer,  followed  by a  Polytron tissue grinder (three  10-s 
bursts; Brinkmann Instruments, Westhury, NY). The homogenate was ad- 
justed to 40% sucrose by addition of 2 ml of 80% sucrose prepared in MBS 
and placed at the bottom of an ultracentrifuge tube. A 5-30% linear sucrose 
gradient (in MBS, lacking Triton X-100) was formed above the homogenate 
and centrifuged at 39,000 rpm for 16-20 h in a SW41  rotor (Beckman In- 
struments, Palo Alto, CA). A light-scattering band confined to fractions 4-7 
is harvested, diluted threefold with MBS,  and pelleted in the microfuge. 
Caveolin-rich membrane domains were snap frozen in liquid nitrogen and 
stored at -80°C. The majority of protein remained within the 40% sucrose 
region of the gradient (lower sucrose, >-90% and insoluble pellet, ,~8%). 
A similar procedure was also used to prepare caveolin-rich membrane do- 
mains from dog and human lung tissue. 
Organelle-specific Membrane Marker Assays 
Markers  for  caveolar  plasma  membrane  (alkaline  phosphatase,  GPI- 
linked),  non-caveolar  plasma  membrane  (alkaline  phosphodiesterase), 
Golgi  (a-mannosidase  II),  lysosomal  (/~-hexosaminidase)  and  ER  (c~- 
glucosidase II) were assayed as described previously (17, 101). Note that 
these assay systems were not affected by the presence or absence of Triton 
X-100 in the initial homogenate. 
Electron Microscopy 
For  routine transmission EM,  samples  were  fixed  with  glutaraldehyde, 
postfixed with OsO4,  and stained with uranyl acetate and lead citrate, as 
described (79). For immuno-gold labeling of sections, samples were fixed 
in 2.5% paraformaldehyde in PBS (pH 7.2) for 2 h on ice. After washing 
with PBS, samples were dehydrated in graded dimethyl formamide and em- 
bedded in Lowicryl K4M resin. Thin sections were cut, incubated with anti- 
caveolin IgG (a 1:50 dilution) and bound antibodies visualized with 10-nm 
gold-conjugated  secondary  IgG  (Zymed  Labs.,  S.  San Francisco,  CA). 
Control experiments indicated that gold-labeling was specifically dependent 
on incubation with anti-caveolin IgG.  Samples were examined under the 
Philips 410 TEM.  Note that in order to preserve immuno-reactivity with 
anti-caveolin IgG (mAb 2234), it was necessary to omit fixation with glu- 
taraldehyde and OsO4, although these conditions are not optimal for struc- 
tural preservation. 
Microsequencing 
For microsequencing, mouse lung caveolin-rich domains were fractionated 
using  the  detergent  Triton  X-I14,  that  separates  hydrophobic  from  hy- 
drophilic proteins.  Briefly,  membrane domains were solubilized in Tris- 
buff¢red saline (10 mM "Iris, pH Z5, 0.15 M  NaCI) containing 1% Triton 
X-114 plus protease inhibitors by incubation at 37°C for 20 min. This condi- 
tion effectively solubilizes caveolin-rich membrane domains (79).  After 
solubilization, extracts were partitioned into detergent-rich (D, detergent) 
and detergent-poor (A, aqueous) phases and proteins were collected by ace- 
tone and TCA precipitation, respectively. After separation by SDS-PAGE 
(10% acrylamide gels), proteins were transferred to Immobilon-P (Milli- 
pore, Bedford, MA) for NH2-terminal sequencing and to nitrocellulose for 
internal sequencing. For internal microsequencing, bands were excised af- 
ter Ponceau S staining and stored in Milli-Q water at -20°C. Excised bands 
were enzymatically digested with the endoproteinase Lys-C in the presence 
of 1% hydrogenated Triton X-100/10% acetonitrile/100 mM Tris-HC1, pH 
8.0, for 24 h at 37°C (34). Eluted peptides were isolated by HPLC and sub- 
jected to NH2-terminal sequencing, using a  (model 447A/120A) pulsed- 
liquid protein sequencer (Appl.  Biosystems,  Foster City,  CA).  NH2-ter- 
minal and internal peptide sequences were used to scan existing databases, 
using the programs ATLAS or BLAST. 
Detection of  G-Actin 
Gc-Globulin (Calbiochem, Inc.) was radio-iodinated to a high specific ac- 
tivity using Iodogen as suggested by the manufacturer (Pierce, Rockford, 
IL). Isolated caveolin-rich membrane domains ('x,200 #g; in 200/~1 MBS) 
were allowed to bind the probe for 1 h at 4°C, and unbound material was 
removed by centrifugation before flotation on sucrose density gradients. 
Control experiments omitting caveolae and competition experiments with 
excess cold Gc-Globulin demonstrated binding specificity. 
Immunoblotting 
Caveolin-rich membrane domains were solubilized with sample buffer and 
separated by a preparative SDS-PAGE mini-gel (10% acrylamide).  After 
transfer, nitrocellulose sheets were cut into 3-ram strips and incubated with 
a variety of different primary antibodies in multi-well trays. Bound antibod- 
ies were visualized with the appropriate secondary antibody, as described 
by the manufacturer (Promega Corp., Madison, WI; Amersham, Bucking- 
hamshire, England). Pertinent positives were used to estimate the relative 
enrichment of these markers in caveolin-rich membrane domains by immu- 
noblotting of gradient fractions (1-8, 5-30% sucrose, 9-12, 40%  sucrose, 
and  13,  insoluble-pellet).  Note  that the insoluble pellet was solubilized 
using  10%  SDS,  repeated cycles of freeze-thawing, and,  finally, dilution 
with sample buffer and boiling. Specific activities of caveolin-rich fractions 
were calculated (arbitrary units/mg protein) and compared with total cellu- 
lar extracts, yielding fold-enrichments. Quantitation was performed with a 
Molecular Dynamics Inc. (Sunnyvale, CA) computing densitometer. To en- 
sure that these estimates were made in the linear range, we (a) used multiple 
autoradiographic exposures and (b) monitored their linearity using the den- 
sitometer, essentially as described (62). As caveolin-rich domains are very 
abundant in lung tissue, a maximum fold-enrichment of only 50 can be ob- 
tained relative to total cell lysates. This maximum is calculated by assuming 
100%  of a  molecule  is confined to these domains,  i.e.,  [(100/600/~g)/ 
(100/30000/zg)]  =  50. 
Northern Blot Analysis 
poly (A)  + RNA  1 (1  #g) prepared from a given murine tissue was sepa- 
rated on formaldehyde-agarose  (1%) gels and blotted on Biotrans nylon 
membranes, UV-cross-linked, and probed with the 32P-labeled  caveolin or 
CD 36 eDNA. RNA preparation and hybridization conditions were as de- 
scribed previously (9, 79), except that blots were washed (2 ×; 30 rain each) 
in 2×  SSC/0.1%  SDS  at 50°C.  cDNAs  for canine caveolin and human 
CD 36 were cloned by PCR amplification of an MDCK eDNA library (79) 
or a  human heart eDNA  library (Stratagene,  Inc.,  La Jolla,  CA),  using 
primers to the known sequences (60, 70). PCR products of the expected size 
were gel purified, cloned into pBluescript II KS +, and their identity veri- 
fied by double-stranded sequencing in both directions. 
Results and Discussion 
Isolation of Caveolin-rich Membrane Domains 
We used an endothelial-rich source, lung tissue,  in an at- 
tempt  to  isolate  caveolin-rich  membrane  domains  from 
whole  tissue  as  caveolin-a  caveolar  marker  protein-is 
most highly expressed in lung (41) (see also Fig. 7, this re- 
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gradient fractions were collected and analyzed by (A) light-scatter- 
ing; (B) Ponceau S staining and (C) anti-caveolin immunoblotting. 
Fractions 1-8 represent the 5-30% sucrose layer, fractions 9-12 are 
the 40%  sucrose cushion and fraction  13 is the insoluble pellet. 
(Fraction 13 was omitted from A, as it represents the insoluble pel- 
let). Note that a single light-scattering  band (fractions 4-7) contained 
"~85% of caveolin  and excluded I>98% of the cellular protein (based 
on independent protein determinations). (D) Comparison of cave- 
olin-rich membrane domains with the total homogenate by Coo- 
massie blue staining. Note that equivalent amounts of protein were 
loaded. Samples were delipidated by acetone precipitation before 
SDS-PAGE to allow better resolution of stained protein bands. 
port). A possible explanation for the abundance of caveolin 
in lung may lie with the observation that caveolae are mor- 
phologically most abundant  in  simple squamous  epithelia 
[defined  as  endothelial  cells  and  type  I  pneumocytes 
('o5,000-10,000  caveolae per  cell;  (86)],  smooth  muscle 
cells  (35),  and  fibrocytes (18)-the  predominant  cellular 
constituents of lung tissue. Quantitative morphometric esti- 
mates of the alveolar cell population indicate that >50 % of 
the cells are simple squamous epithelia ('o42% endothelial 
cells and "o11% type I pneumocytes) and "o35% interstitial 
cells that include primarily smooth muscle cells (pericytes), 
fibrocytes, and macrophages (90). Although the type I pneu- 
mocytes represent  "o11% of the cell population,  they are 
thought to cover 97-98% of the alveolar surface (,o140 m 2 
in humans), are twice the volume and four times the surface 
area of endothelial cells; endothelial cells cover roughly the 
same surface area. In contrast, type II pneumocytes occupy 
only 2-3 % of the alveolar surface (90). 
To this system, we applied our recently described proce- 
dure  for isolating caveolin-rich membrane domains  from 
cultured cells, which depends on the stringent criteria of (a) 
resistance to solubilization by Triton X-100 at 4°C and (b) 
buoyancy at a specific density in sucrose gradients. A single 
light-scattering band corresponding to a low-density, Triton- 
insoluble complex was observed mainly in fractions 5-6 of 
these gradients (the "o15-20 % sucrose region; Fig. 1 A). The 
flotation  and  protein  composition  of this  light-scattering 
Triton-insoluble complex was unaffected when  1%  Triton 
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cating that this Triton-insoluble complex does not "form"  be- 
cause of a lack of Triton in the upper portion of the gradient. 
These membrane domains excluded >198 % of the total cellu- 
lar protein which remained within the bottom-loaded 40 % 
sucrose layer (fractions 9-13;  Fig.  1, B and C), and their 
polypeptide composition was clearly distinct from the total 
homogenate (Fig.  1 D). A yield of ~600 #g was obtained 
from 30 mg of total protein-representing ~2 % of the start- 
ing material.  2 As a yield of 0.05 % was previously obtained 
from cultured MDCK cells  (canine kidney origin;  [79]), 
these complexes are r~40-fold mroe abundant in lung tissue. 
This is consistent with the observation that caveolin expres- 
sion is highest in lung tissue and virtually undetectable in re- 
nal tissue (41) (see also Fig. 7, this report). 
As compared with other gradient fractions, these com- 
plexes retained known caveolar marker proteins (~85 % of 
caveolin and ~55% of alkaline phosphatase-a GPI-linked 
protein) and excluded I>98  % of three integral plasma mem- 
brane protein markers (alkaline phosphodiesterase, Na+K  ÷- 
ATPase,  and  p45)  and  I>99.6% of the  other  organeUe- 
specific membrane markers tested (Fig. 2).  Similarly, our 
previous findings with cultured cells indicated that MDCK- 
derived caveolin-rich domains exclude ~>99  % of  cell surface- 
labeled proteins and a battery of organelle-specific marker 
enzymes for non-caveolar plasma membrane, Golgi, lyso- 
somes, and ER (79). 
By transmission EM,  caveolin-rich membrane domains 
appeared as ~50-100-nm vesicular structures and as mem- 
brane fragments that were often curved or U-shaped (Fig. 3 
A). This variation in shape is in accordance with previous 
studies indicating that caveolae may be flat or invaginated 
and may exist singly or in bunches (76, 84); however, deeply 
invaginated caveolae are most conspicuous and appear as 
flasks attached perpendicularly to the plasma membrane. If 
these curved-domains or open-flasks were then dissociated 
from  the  plasma  membrane  and,  therefore,  no  longer 
oriented perpendicularly to the plane of the membrane, sec- 
tioning of these structures would be expected to yield fields 
of 'sealed' vesicles and curved membrane fragments. This 
could also contribute to the apparent variation in shape we 
observe. 
These structures were heavily labeled when thin sections 
were stained with anti-caveolin IgG, indicating that these 
complexes contain caveolin (Fig. 3 B). This is in accordance 
with our observation that *85 % of caveolin is recovered 
within these membrane domains. These results also demon- 
2.  Empirically, we find that 400 mg of lung tissue results in •30  nag of 
detectable protein, 7.5 % of the wet weight. As protein represents '~15-22 % 
of the wet weight of various organs, our yield caveolin-rich domains may 
be an overestimate due to an underestimate of the starting material. This 
difference may reflect the abundance of connective tissue components in 
lung that cannot be completely solubilized in SDS for protein determina- 
tions. If we recalculate our yield, using an estimated protein content of 
15-22%, then these domains represent "~0.65-1%. Even with this "lower 
yield" caveolin-rich domains would still be  10-20-fold more abundant in 
lung than previously observed for renal epithelial cells, in accordance with 
tissue Northerns. In addition, this lower yield would also increase the fold- 
enrichments we observe by a factor of two-to-three, but would not change 
the amount of a given protein that we have expressed as a percentage of the 
total homogenate. 
strate that the caveolin content of these domains is not con- 
tributed by a minor fraction of these complexes, as >90 % 
of the discernable structures were immuno-labeled. 
Characterization of Caveolin-rich 
Membrane Domains 
To identify the major protein components of caveolin-rich 
membrane domains, we subjected these complexes to micro- 
sequencing. We first separated their components into hydro- 
phobic and hydrophilic fractions by partitioning with the 
detergent Triton X-114 and subjected them to analysis by 
SDS-PAGE  (Fig. 4).  After Coomassie-blue staining, most 
proteins  were  found to  partition  with  the  detergent-rich 
phase.  We identified a  major 22-kD  band as caveolin by 
immuno-blotting with mono-specific antibodies (not shown). 
As expected for an integral membrane protein, caveolin par- 
titioned with the detergent phase. NH2-terminal and inter- 
nal sequencing of the major protein bands revealed multiple 
GPI-linked proteins, certain cell surface integral membrane 
proteins (CD 36, RAGE, plasma membrane porin and caveo- 
lin),  a  v-Src/pkc  substrate  (annexin ID,  GTPases  (G c¢  i 
subunits, Rap 1, TC 21, and Rab 5), putative luminal content 
molecules (albumin, SPA, and osteopontin), and compo- 
nents of the actin-based cytoskeleton (Fig. 4; Table I).  (A 
few novel protein sequences corresponding to 3 or more un- 
known proteins were also detected). These results support 
our enzyme-marker studies demonstrating that these domains 
exclude markers for non-caveolar plasma membrane, Golgi, 
lysosomes, and ER, but are enriched in a GPI-linked marker 
protein and caveolin (see above). As solubilized caveolin ex- 
ists as a hetero-oligomeric complex (61) with other unknown 
integral cell surface proteins of 85, 50, 30-40,  and 14 kD, 
CD 36 (85 kD), RAGE (45--48 kD), and plasma membrane 
porin (33 kD) could represent the other cell surface compo- 
nents of these immuno-isolated caveolin hetero-oligomers. 
As monomeric actin has recently been visualized in intact 
cells as a plasma membrane-associated "beaded" structure 
by  fluorescence  microscopy  with  a  specific  probe  (Gc- 
Globulin) that recognizes only G-actin (24), these structures 
might represent caveolae. This would explain our observa- 
tion that actin is one of the most abundant protein com- 
ponents in caveolin-rich membrane domains.  To test this 
hypothesis,  we  examined  the  binding  of radio-iodinated 
Gc-Globulin to isolated caveolin-rich membrane domains. 
These structures specifically bound Gc-Globulin as deter- 
mined by flotation in sucrose density gradients (Fig. 5), indi- 
cating that they contain G-actin. This is in accordance with 
the observation that monomeric actin beaded structures and 
caveolin are both concentrated at the leading edge of motile 
cells (24, 76). In addition, the cytoplasmic surface of caveo- 
lae can be specifically labeled in situ with an actin-binding 
protein, i.e., gold-conjugated myosin II-subfragment 1 (51). 
In support of  our results from micro-sequencing, immuno- 
blotting  of caveolin-rich  membrane  domains  revealed  a 
significant  number  of positives.  These  antibody  studies 
confirmed the identities of a number of components we as- 
signed based on micro-sequence analysis, i.e., CD 36, cav- 
eolin, G protein ct i subunits, annexin II, Rap-l, actin, gelso- 
lin, and non-muscle myosin II (Fig. 6). The identity of Rab 5 
was also confirmed by immuno-blotting (not shown). Perti- 
Lisanti et al.  Caveolae, Atherosclerosis,  and Cell Transformation  115 Figure 2.  Continued  next page. Figure 2. Profiles of organdie-specific  membrane markers across 
the gradient.  (,4) Cellular protein; (B) caveolin; (C) alkaline phos- 
phatase;  (D)  alkaline  phosphodiesterase;  (E)  Na+K+-ATPase, 
B-subunit; (F) p45; (G) cx-mannosidase  II; (H) B-hexosaminidase; 
(I) {x-glucosidase II. Fractions  1, 2, and 3 represent caveolin-rich 
membrane domains, the 40% lower sucrose layer, and the pellet, 
respectively. The sum of  the protein/activity in these three fractions 
was equivalent to the amount present  in total cell homogenates. 
Note that caveolin-rich domains (fraction 1) retain '~85 % of  caveolin 
and '~55 % of alkaline phosphatase,  and exclude ~>98  % of integral 
plasma membrane markers (alkaline phosphodiesterase,  Na+K  +- 
ATPase, and p45) and/>99.6 % of  the other organelle-specific mem- 
brane markers tested.  When these  results are expressed as fold- 
enrichments,  caveolin-rich  domains  are  enriched  in  caveolar 
marker proteins (caveolin, '~42.5-fold, and alkaline phosphatase- 
a GPI-linked protein,  ~27.5-fold),  while they exclude markers for 
plasma membrane (~<l-fold), Golgi (c~-mannosidase  ]I; '~0.1-fold), 
lysosomes (B-hexosaminidase; ~o0.2-fold), and ER (~x-glucosidase 
II; '~0.035-fold). 
Note that I)45 is a non-GPI-linked plasma membrane protein that 
can be labeled from the cell surface, partitions with the hydropho- 
bic phase of Triton X-114 extracts, and is inextractable by washing 
with carbonate or NaOH, behaving as an integral membrane pro- 
tein (46). 
nent positives were used in studies of fractionated gradients 
to estimate whether these molecules were specifically en- 
riched in caveolin-rich membrane domains, relative to total 
cellular extracts (Fig.  6, A-G).  We find that CD 36,  cyto- 
skeletal elements, non-receptor tyrosine kinases, a v-Src/pkc 
substrate (annexin II), SH-2 adaptor proteins, a protein tyro- 
sine phosphatase (PTP-1D),  protein kinase C  or,  MAP ki- 
nase (42 kD, ERK-2 isoform), casein kinase II, PI-3 kinase 
(p85),  hetero-trimeric  G-protein  subunits,  and  the  Ras- 
related GTPases, Rap 1 (Krev-1; Ras tumor suppressor gene) 
and Rap 2-are  all associated with caveolin-rich domains. 
Although the enrichment of a given protein varied from as 
high as 50-fold (representing 100% of a given molecule) to 
as low as threefold (representing 6 % of the total cellular ex- 
pression) in one case, these enrichments were greater than 
that observed for non-caveolar plasma membrane markers 
(<l.0-fold) or other organelle-specific marker enzymes (0.035- 
0.2-fold;  see legend of Fig.  2).  In contrast to the enriched 
molecules,  several signaling molecules are specifically ex- 
Figure 3.  Visualization of caveolin-rich domains by transmission 
electron  microscopy.  (A) These domains  appeared  as  '~100-nm 
vesicular structures (arrowheads) and as curved or U-shaped mem- 
brane fragments (arrows). Bar, 0.1 #m; (B) Caveolin-rich domains 
were  fixed with  paraformaidehyde  and  processed  for immuno- 
labeling  with  anti-caveolin  IgG  (see  Materials  and  Methods). 
Bound IgG were visualized with a 10-rim gold-conjugated second- 
ary antibody. Magnification is the same as in A. Note that in order 
to preserve immuno-reactivity with anti-caveolin IgG (mAb 2234), 
it was necessary  to omit fixation with glutaraldehyde and OsO4. 
cluded from these complexes (including Rho A and B, Rab 
3D, Ras, Ras-GAP, PLC-% RB), remaining confined to the 
lower sucrose layer (40%  sucrose loading zone) (Fig. 6, D 
and H). Other well known signaling molecules were also ex- 
cluded  (MAP  kinase  [44  kD,  ERK-1  isoform]  and  MEK 
[MAP kinase kinase or ERK kinase]; not shown). Similarly, 
our previous  results  with  caveolin-rich domains  prepared 
from tissue-cultured cells indicated that Ras-GAP and PLC-3, 
were excluded from these domains (79). 
Consistent with the hypothesis that CD  36 represents a 
transmembrane component of caveolin-rich domains in situ, 
Northern analysis reveals that CD 36 and caveolin share a 
similar  tissue  distribution  and  both  are  most  highly  ex- 
pressed in lung and muscle tissues (Fig. 7), where caveolae 
are morphologically abundant.  Similarly, the expression of 
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TX-114 
Identity  Sequence  Phase 
Molecular Weight (kD) 
Reported  Apparent 
GPI-linked 
membrane  KLAQTXXNIP  (13  D 
dipeptidase 
carbonic  KDNVRPLQ  (I)  D 
anhydrase IV 
Thy-1  XEVXAGSH  (N)  D 
Transmembrane 
CD36  GXDRNXGLIA  (N)  D 
KTGTTVYRQFX..  (I) 
IFDVQNPDDVA 
KELLWGY  (13 
RAGE (receptor  KXNYRVXVYQ..  (13 
for  advanced  IXG 
glycosylation  KXNYXVXVYQ..  (13 
end products)  IPGKPEIVDPA 
plasma  KXRVTQSNFAV..  (13 
membrane  GYK 
porin  KXNTDNTL  (1) 
KXD/LEFQL/VX..  (13 
XNXXD 
caveolin;  KEIDLVNRDPK  (13 
VIP-21  KIDFEDVIAEPE...  (13 
GTXSFXXI 
Cytoplasmically oriented signaling molecules 
G-protein,  KXXGIVEXHF... 
or, i subunits  XFK 
annexin II,  KSALSGHLETV.. 
heavy chain  ILGLLK 
KGDLENAFXNL.. 
XQXIQN 
KLMVALAK 
Rap 1  KINVNEIFYDL... 
VXQINXK 
KXXQXFALVYS... 
IXA 
TC 2 I*  KXXYMXXXAK 
Rab 5  RGAQXA 
Cytoskeletal elements 
gelsolin 
actin 
XVEHPEFLXA 
KEITALAPSTMK 
KAGFAGDDAP... 
RAVFPSIV 
KDLYANTVLSG.. 
GTTMYPGIAD 
KYPIE 
myosin,  KEAFNMIDQN... 
regulatory  XDGFIDK 
light chain 2  KLNGTDPEDVI... 
XNAFAXFD 
Endocytic ligands/fluid phase uptake? 
albumin  EAHKSEIAHRY.. 
NDLG 
KSEIAXXYND... 
LXE 
D 
D 
D 
(I)  D 
(13  A 
(I) 
47 
35-39 
25-30 
88 
35-50 
31 
21-29 
39-41 
36 
45 
35 
28-31 
85 
48/45 
33 
25 
40 
35 
(13 
(13  D  21  22 
(I) 
(I)  D  21  22 
(N)  D  25  14-17 
(N)  D  9O  9O 
(13  D  42  42 
(13 
(13 
(I) 
(13  O  20  18 
(13 
(N)  A  68  68 
(D  D  68  65 
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Identity 
Molecular Weight (kD) 
TX-114 
Sequence  Phase  Reported  Apparent 
pulmonary 
surfactant 
protein A 
(SP-A) 
osteopontin; 
SSP-I,  secreted 
phosphoprotein  I 
KGEPGERGLP..  (I)  D  28-36  35/40 
GFPAYLD 
KXQILQTMGVL..  (I) 
SLQGSML 
TEVXAGSPGIP..  (N)  A  28-36  35 
GTPGNXGL 
KGEPGERGLP..  (I) 
GFPAXXXEELQT.. 
ALYXIK 
DSGXXXEXQ  (N)  D  45-55  35-38 
* TC 21, a member  of the Rap sub-family  of GTPases, is ",,57  % identical to Rap 1 (28). N, NH2-terminal  sequencing; L internal sequencing; D, detergent  phase; 
A. aqueous phase. 
the RAGE protein is also highest in lung and muscle tissues 
(19). 
To diminish  the possibility  that caveolin-rich  membrane 
domains "form" because of the inclusion of detergent during 
the initial homogenization step, we attempted to isolate these 
complexes in the absence of detergent.  For this purpose, we 
used an established protocol for the isolation of "light vesi- 
cles" from lymphoma or endothelial cells (Bourguignon,  L., 
N. Iida, L. Sobrin, and G. J. Bourguignon.  1993. Identifica- 
tion of an IP3 receptor in endothelial  cells. Mol.  Biol.  Cell. 
4:234a.)  (16) that does not involve detergent.  These vesicles 
are  50-100-am  in  diameter  and  are  enriched  in  the 
IP3-receptor,  a  caveolar marker protein  (37),  but  exclude 
other markers for plasma membrane, Golgi, lysosomes, and 
ER (16). When we isolated these light vesicles from lung- 
an endothelial-rich  source-we  found  (a) that they contain 
caveolin; (b) that they have a similar buoyant density and pro- 
tein composition as caveolin-rich membrane domains  (Fig. 
8); and (c) these light vesicles are Triton-resistant ('~50-70% 
Triton-insoluble by protein determinations).  In addition, our 
preliminary  studies  indicate  that  these  light  vesicles  also 
contain a  subset of signaling molecules  (non-receptor tyro- 
Figure 4. Summary of the pro- 
tein components of caveolin- 
rich  domains  identified  by 
microsequence analysis. Coo- 
massie blue-stained profile of 
caveolin-rich domains fraction- 
ated with the detergent Triton 
X-114.  Note  that  most  pro- 
teins partition with the deter- 
gent-rich  phase  (Det),  while 
few are associated with the de- 
tergent-poor phase (Aq).  The 
major Coomassie blue-stained 
bands were subjected to micro- 
sequence  analysis  and  their 
assigned identities are shown 
(see Table I for the specific se- 
quences). Note that an unusu- 
ally low molecular weight was 
obtained  for  Rab  5  (14-17 
kD).  This  is  consistent  with 
the recent observation that the 
NH2-terminal domain of Rab 5 
is  extremely  susceptible  to 
proteolysis (91).  The identity 
of Rab  5  was  independently 
confirmed by immuno-blotting 
(not shown). 
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teins, Rap GTPases, cytoskeletal elements, protein kinase C 
c~, and MAP kinase, 42 kD), while excluding others (RB, 
PLC-% and Ras-GAP)-as we have shown for caveolin-rich 
membrane domains (data not shown). 
Prospects 
In this paper, we report the isolation of cave.olin-rich mem- 
brane domains from whole tissue. The known functions of 
the molecules we identified are summarized in Table II and 
are correlated with earlier morphological studies of caveolae 
(plasmalemmal vesicles) in situ. The components we iden- 
tified may represent resident elements of caveolae at steady- 
state, whereas other depleted molecules may have a regu- 
lated affiliation (possibly ligand-induced) or may have been 
dissociated by the harsh treatments inherent in subceUular 
fractionation. As such, our current results provide a critical 
starting point and a systematic basis for future immunolocal- 
ization studies. 
As many of the proteins we have identified as components 
of caveolin-rich membrane domains are lipid modified, the 
possibility has been raised that these components associate 
simply because of the inclusion of a detergent during the ini- 
tial homogenization step. We feel that this is unlikely for the 
following reasons: (a) GPI is added at the level of the ER, 
however,  GPI-linked proteins become Triton-insoluble and 
buoyant only after exiting the ER and entering the Golgi 
complex, indicating that their insolubility is specific to their 
immediate micro-environment (20);  (b) we have identified a 
subset of small GTPases (Rap 1, Rap 2, and TC 21) that are 
lipid modified and are associated with caveolin-rich mem- 
brane domains. In contrast, other Ras-related GTPases that 
share over 50%  sequence identity with the Rap family and 
undergo the same lipid-modifications were excluded from 
these complexes: (c) other investigators have demonstrated 
that multiple hetero-trimeric G proteins are concentrated in 
the same complex that exists in the absence of detergent, is 
resistant to dissociation by Triton-like detergents, and is dis- 
persed by octyl-glucoside ([25, 53] and references therein), 
as we have observed for caveolin-rich membrane domains 
(this  report  and  [791); and  (d)  preliminary  experiments 
isolating caveolin-rich domains in the absence of detergent 
suggests that these domains have a similar protein composi- 
tion, that is independent of detergent extraction, and that 
they exist in cells that have not been exposed to Triton X-100 
(see above). Taken together, these results argue against non- 
specific aggregation due to lipid modification. More likely, 
their Triton-insolubility derives from their immediate lipid 
micro-environment that is rich in glyco-sphingolipids as sug- 
gested previously (20), since glyco-sphingolipids are local- 
ized to cell surface caveolae (66) and glyco-sphingolipids are 
intrinsically Triton-insoluble (45, 94). 
Tyrosine phosphorylation of a  small  subset of cellular 
proteins  is  thought  to  play  a  critical  regulatory  role  in 
mitogenic-signaling events. One of these substrates for tyro- 
sine phosphorylation, caveolin, was first identified as a ma- 
jor target of v-Src in RSV-transformed cells (40, 42).  This 
initial finding suggested a relationship between caveolin, cel- 
lular transformation, and transmembrane signaling. Consis- 
tent with these observations, we find that known signaling 
molecules are associated with caveolin-rich membrane do- 
mains (this report and [79]).  These findings could provide 
a compartmental framework for understanding certain trans- 
membrane-signaling events. In support of this proposal, sev- 
eral independent reports demonstrate both physical and func- 
tional interactions, "cross-talk; between G-protein-coupled 
receptors, hetero-trimeric G-proteins, non-receptor tyrosine 
kinases, protein kinase C, MAP kinase, SH-2 adaptors, and 
Ras-related signaling molecules (2, 4, 5, 44, 47, 50, 67, 77, 
87,  97,  98).  Morphological studies independently suggest 
that multiple G-protein-coupled receptors, G-protein modi- 
fying bacterial toxins, and adenylate cyclase are localized to 
or internalized by caveolar domains (See Introduction). In 
addition, recent evidence indicates that activators of protein 
kinase C cause caveolae to undergo dramatic morphological 
changes which functionally regulates the caveolar uptake of 
small molecules, such as folate (88). In this regard, caveolin 
undergoes phosphorylation on both tyrosine and serine resi- 
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Figure 5. Detection of monomeric actin in caveolin-rich  domains. 
The buoyancy of radio-iodinated Gc-Globulin was examined by 
density-gradient  centrifugation as for the isolation of caveolin-rich 
domains. (tl) Gc-Globulin alone; (B) Gc-Globulin bound to cave- 
olin-rich domains; (C) graphical representation of B.  Note that 
only bound Gc-Globulin attains buoyancy  and cofractionates with 
caveolin-rich domains, suggesting that these  structures contain 
G-actin, 
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Molecule  Known functions and relationship to caveolae 
albumin 
osteopontin 
GPI-linked 
proteins 
caveolin 
CD 36 
RAGE 
plasma 
membrane 
porin 
Src-like 
kinases 
protein 
kinase C 
gelsolin 
actin 
hetero- 
trimeric 
G-proteins 
rap  1 
rab 5 
SP-A 
Serum carrier for amino acids, fatty acids, sterols, hormones, bile acids, and bilirubin (81).  Undergoes receptor-mediated 
transeytosis across endothelial cells via caveolae (38). 
Widely expressed RGD-containing secreted glyco-phospho-protein with intrinsic Ca2+-binding and phosphorylation activity. 
Associated with the luminal (apical) aspect of epithelial cells, including lung (21).  Transduces cytoskeletal rearrangements 
via the intergrin (otVfl3) (65) and the plasma membrane Ca2+-ATPase, a known caveolar component (36). 
Diverse group of proteins anchored to the cell surface via a glycophospholipid tail (33).  Are found concentrated in plas- 
malemmal caveolae (106).  Can act as signaling molecules that stimulate mitogenesis and cytoplasmic tyrosine phosphory- 
lation (75,  93) and physically associate with multiple Src-like kinases (Lyn, Fyn, Lck, and c-Yes)  (27, 79, 92, 93, 96). 
Also, GPI-linked proteins can function as receptors for the caveolar uptake of small molecules via a process termed 
potocytosis (8). 
22-kD transmembrane phospho-protein. Originally identified as a major v-Src substrate in RSV-transformed cells (40). 
Both cellular transformation and cave.olin phosphorylation ate dependent on the membrane attachment of v-Src (40).  Re- 
cently identified as a caveolar protein component by immuno-gold labeling in situ (29,  60, 76). 
Widely distributed glycoprotein receptor for oxidized LDL, expressed in both endothelial cells and macrophages (30). 
Also binds long chain fatty acids and physically associates with multiple Src-like kinases (Lyn, Fyn, c-Yes, and c-Src) (1, 
49).  Contains a consensus sequence for interaction with Src-like kinases in its short cytoplasmic domain. Interestingly, en- 
dothelial cell caveolae bind, endocytose and transcytose LDL, and modified forms of LDL (89,  100). 
Receptor for advanced glycosylation end products (AGEs), including glycated LDL (68).  Also functions as a signaling 
molecule (68). Previous localization studies reveal the presence of RAGE in caveolae (80) and AGEs undergo endothelial 
transcytois via eaveolae (31,  105).  As RAGE is an endogenous lectin, it could function to recognize GPI or other glyco- 
lipids concentrated in eaveolae. 
Voltage-dependent anion channel; slight preference for anions (2:1), with a molecular cut off of 'x,6 kD.  Localized to the 
cell surface, but homologous with mitochondrial porins (12, 56).  May have implications for the uptake of small molecules 
through caveolae as potocytosis occurs via an unknown anion-transport protein (57).  Interestingly, plasma membrane po- 
rin has recently been immunolocalized to plasmalemmal vesicles in situ (72). 
Caveolin and annexin II (an actin-binding protein involved in membrane fusion events) were first  identified as major v-Src 
substrates in RSV-transformed cells (26, 40). 
Activators of protein kinase C prevent the uptake of small molecules via caveolae (88).  Both  caveolin and annexin II con- 
tain consensus sites for protein kinase C phosphorylation. 
Severs and sequesters actin in a monomeric state  (54).  Attaches to PIP2, a precursor for IP3 and diacylglycerol, which act 
on the IP3-receptor  and protein kinase C, respectively. The latter molecules have been shown to localize to either caveo- 
lae (37) or caveolin-rich domains (this report). 
The cytoplasmic coat of caveolae can be labeled in situ with an actin-binding protein, gold-conjugated myosin subfrag- 
ment I (51, 52).  Also, dystrophin (an actin-binding protein) has been immunolocalized to caveolae in smooth muscle cells 
(69).  Here, we identify actin and three actin-binding proteins (gelsolin, annexin II, and myosin II) as components of 
caveolin-rich membrane domains by microsequencing. 
Dual role in signal transduction and cellular transport. Implicated in TGN vesicular budding and transcytosis (13).  Sub- 
strates for glycolipid binding bacterial toxins, such as cholera toxin-that is internalized via caveolae (66).  Certain G-pro- 
tein coupled-receptors have been localized to caveolae in situ and this association is agonist-induced and reversible (73,  74). 
Ras-related GTPase (11)  suppresses the tumorigenicity of ras and middle T antigen (55, 58).  Middle T is thought to exert 
its effect through activation of Src-like kinases. Rap 1 is the mammalian homologue of RSR1, a gene product that con- 
trols yeast cell polarity (39,  78). Interestingly, caveolin and associated  proteins are thought to participate in the generation 
of apical cell polarity in epithelial cells (29,  61, 79,  107).  Given the antagonistic relationship between rap  1 and ras, it is 
interesting to note that expression of activated ras selectively disrupts apical cell polarity in epithelia (82) and leads to the 
selective intracellular retention of GPI-linked proteins in fibroblasts (10). 
Plasma membrane and early endosomal marker involved in endosome-endosome fusion events (22).  This association is 
consistent with evidence that caveolae participate in endocytic and transcytotic transport processes. 
Surfactant protein A, a member of the family of C-type lectins, recognizes cell surface glyco-sphingolipids, including 
galactosyl-ceramide, and asialo-GM2  (3).  In addition, SP-A has been immunolocalized in part to plasma membrane- 
associated vesicular structures (50-100 nm in diameter) in situ (104). 
dues in vivo and in vitro (40, 79) and contains conserved cy- 
toplasmic consensus sites for phosphorylation by protein ki- 
nase C  (Ser-37) and casein kinase II (Ser-88). Similarly, the 
unique NH2 terminus of annexin II is a  dual substrate  for 
v-Src (Tyr-23) and protein kinase C  (Ser-25)  (26). 
Finally, it should be noted that  several proteins that  we 
have identified here as  components of caveolin-rich mem- 
brane domains  by  micro-sequencing of their  major  Coo- 
massie-blue  stained  bands  (caveolin,  RAGE,  GPI-linked 
proteins, plasma membrane porin, albumin, actin, and SP- 
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The Journal of Cell Biology, Volume  126, 1994  122 Figure 6. Immunoblotting of caveolin-rich domains. An aliquot of each 1-ml gradient fraction (1-8, 5-30%  sucrose; 9-12; 40%  sucrose; 
and 13, insoluble-pellet) was collected by acetone precipitation, separated by SDS-PAGE, and transferred to nitrocellulose. Fractions 1-13 
were then  subjected to immunoblotting with  antibodies to  signaling molecules or cytoskeletal elements.  Fractions  4-7 represent the 
cave.olin-rich membrane domains. Note that in the case of immunoblotting with anti-CD 36 IgG, human lung tissue was used as available 
antibodies do not react across species. The amount of given protein re,  covered in caveolin-rich domains is expressed as a percentage relative 
to the total homogenate. To calculate the fold-enrichment, divide this percentage by a factor of 2 (See Materials and Methods). (A) Non- 
receptor tyrosine kinases, c-Src, c-Yes, Lyn, Fyn, Lck, c-Fgr,  JAK-2. ('°85-95%).  (B) Phospho-tyrosine related molecules, v-Src-pkc sub- 
strate (annexin ll-heavy chain, "o65%), protein tyrosine phosphatase (PTP-1D;  "o55%), SH-2 adaptor molecules (Vav, "o90-98 %; GRB-2, 
"o12  %; ISGF,, "o8 %; SHC, "o7  %  ). Note that certain SH-2 adaptor molecules-GRB-2, ISGF, and SHC-were least associated. The steady- 
state distribution of some of these adaptor molecules could reflect a regulated affiliation with caveolin-rich domains. (C) Hetero-trimeric 
G proteins, ct-subunits  (s, ,'o80  %; i 1,2, "o80  %; i 3, ,x,55 %; q,11, "o50 %) and/~-subunit ('o40 %). (D) Ras-related GTP-binding proteins. 
Rap 1, "o33 %; Rap 2, '~30%. Note that Ras, Rho A, Rho B, and Rob 3D are excluded. (E) Other kinases. PKC ct, "o80%; MAP-kinase, 
"o42%; casein kinase H (ct and c~' subunits,  "o16%); PI-3 kinase (p85, "o6%). Note that of the kinases detected, PI-3 kinase (p85) was 
least associated. (F) Cytoskeletal elements, non-muscle myosin ll-heavy chain, ,'o75 %; actin, "o30%; gelsolin, "o20%. (G) Transmem- 
brane CD-36, "o90-95%.  (H) Additional examples of excluded signaling molecules. Ras-GAP, PLC-% RB. 
A), have been previously morphologically localized to plas- 
malemmal vesicles or caveolae in situ (see Introduction and 
Table II for specific references).  Similarly, others have dem- 
onstrated  that  specific  lipids  (such  as glyco-sphingolipids) 
that are highly enriched in caveolin-rich complexes (20), are 
morphologically  localized  to  caveolae  in  situ  (66).  These 
biochemical  and  morphological  correlates  provide  further 
evidence that these domains  represent isolated caveolae. 
In  conclusion,  isolation  of caveolin-rich  membrane  do- 
mains  from  lung  tissue  has  allowed  us  to  identify  a  sig- 
nificant number of their protein components.  As almost all 
of these  molecules  are  known  proteins  whose  genes  have 
been cloned and to which well-characterized antibodies have 
been  generated,  the availability  of these  molecular probes 
should  facilitate the evaluation of these putative  functional 
interactions  in situ. 
Figure 7. Caveolin and CD 36 are both highly expressed in lung and 
muscle tissues.  Comparative Northern blot analysis of the tissue 
distribution of caveolin and CD 36. Each lane contains 1/~g of poly 
(A)  + RNA prepared from a given murine tissue, as indicated.  Af- 
ter the initial hybridization with caveolin or CD 36 eDNA probes, 
the blot was stripped and repmbed with an actin cDNA probe (as 
published previously, see Baldini et al.,  1992  [Fig.  4  within])  or 
a murine cytosolic hsp 70 cDNA probe (not shown) as controls for 
equal loading. 
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